Cancer Du Sein Inflammatoire Chez La Femme Camerounaise
Authors: Pierre R Binyom , Belemlilga G. L. Hermann ZarÃ© Cyprien , Ymele F Fouelifack , Georges BwÃ©llÃ© , Aristide Bang , Sosso Maurice AurÃ©lien NgowÃ© NgowÃ© 
Published: January 2021

Introduction : Le cancer du sein inflammatoire (CSI), est relativement frÃ©quent chez la jeune femme camerounaise. Lâ€™objectif Ã©tait de prÃ©senter les caractÃ©ristiques du CSI en milieu camerounais. Patients et mÃ©thodes : Il sâ€™est agi dâ€™une Ã©tude transversale descriptive, multicentrique Ã collecte rÃ©trospective allant du 1er Janvier 2010 au 31 DÃ©cembre 2014. Ont Ã©tÃ© inclues toutes les femmes de nationalitÃ© camerounaise diagnostiquÃ©es pour un CSI histologiquement confirmÃ©. RÃ©sultats : Vingt-et-un cas de CSI ont Ã©tÃ© colligÃ©s et reprÃ©sentaient 3% de lâ€™ensemble des mastopathies dans quatre hÃ´pitaux. Lâ€™Ã¢ge moyen des patientes Ã©tait de 37,7 ans. Quatorze (66,7%) femmes avaient consultÃ© aprÃ¨s un intervalle supÃ©rieur Ã six mois. La localisation de la tumeur Ã©tait unilatÃ©rale dans tous les cas. Dix-huit (85,7%) des patientes avaient un statut ganglionnaire cliniquement positif. La taille tumorale mÃ©diane Ã©tait de 5cm. Les patientes Ã©taient classÃ©es respectivement PEV3 dans 52,4%, PEV2 dans 28, 6% et PEV1 dans 19%. Huit patientes (38%) Ã©taient mÃ©tastatiques. Seize (76,2%) femmes avaient une nÃ©gativitÃ© aux rÃ©cepteurs Å“strogÃ¨nes et progestÃ©rones. Le carcinome canalaire infiltrant Ã©tait le plus frÃ©quent (66,6%). Treize (62%) patientes ont recouru au traitement traditionnel rituel. Une chimiothÃ©rapie nÃ©oadjuvante et adjuvante Ã©tait systÃ©matiquement instituÃ©e. Dix-huit (85,7%) patientes Ã©taient opÃ©rables et avaient bÃ©nÃ©ficiÃ© dâ€™une mastectomie. Six cas de rÃ©cidive ont Ã©tÃ© notÃ©s au cours du suivi. La survie Ã cinq ans Ã©tait de 42, 9%. Conclusion : Lâ€™utilisation systÃ©matique de la chimiothÃ©rapie neoadjuvante et adjuvante a amÃ©liorÃ© le pronostic du CSI.
Introduction: Inflammatory breast cancer (IBC) is relatively common in young Cameroonian women. This paper aims to present the characteristics of the IBC in the Cameroonian environment. Patients and Methods: The paper uses a descriptive, multicentre cross-sectional study with retrospective collection from 1st of January 2010 to 31st of December 2014. All Cameroonian women affected by an IBC diagnosed and histologically confirmed were included in the study. Results: Twenty-one cases of IBC, which represented 3% of all treated mastopathies, was collected in four Church Hospitals. The mean age of the patients was 37.7 years. Fourteen (66.7%) consulted after an interval more than six months. The location of the tumour was unilateral in all of the cases. Eighteen (85.7%) of the patients had clinically positive lymph node status. The median tumour size was 5cm. The patients were classified into PEV3 52.4%, PEV2 28.6% and PEV1 19%, respectively. Eight patients (38%) were metastatic. Sixteen (76.2%) women had negative oestrogen and progesterone receptors. The most common histologic type was invasive ductal carcinoma with 66.6% of cases. Thirteen (62%) patients used traditional ritual treatment. Neo-adjuvant and adjuvant chemotherapy were systematically instituted. Eighteen (85.7%) patients were operable and had undergone mastectomy. Six (33.3%) cases of recurrence were observed during the follow-up. The 5-years survival was 42.9%. Conclusion: Systematic use of neo-adjuvant and adjuvant chemotherapy improved the prognosis of IBC.